End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
347.7 INR | +3.21% | -0.01% | +10.47% |
May. 28 | Supriya Lifescience Limited Approves Executive Changes | CI |
May. 28 | Supriya Lifescience Limited Recommends Final Dividend for the Fiscal 2024 | CI |
Sales 2024 | 5.7B 68.33M | Sales 2025 * | 6.85B 82.06M | Capitalization | 27.98B 335M |
---|---|---|---|---|---|
Net income 2024 | 1.19B 14.27M | Net income 2025 * | 1.45B 17.36M | EV / Sales 2024 | 4.7 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.09 x |
P/E ratio 2024 |
22.5
x | P/E ratio 2025 * |
19.3
x | Employees | 392 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 29.71% |
1 day | +3.21% | ||
1 week | -0.01% | ||
Current month | -5.27% | ||
1 month | -15.31% | ||
3 months | -6.05% | ||
6 months | +23.47% | ||
Current year | +10.47% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 22-10-02 | |
Director of Finance/CFO | - | 23-01-22 | |
Chief Operating Officer | - | 04-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 21-03-24 | |
Director/Board Member | 65 | 21-03-24 | |
Founder | 68 | 08-03-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 347.7 | +3.21% | 195,376 |
24-06-04 | 336.9 | -6.22% | 493,213 |
24-06-03 | 359.2 | -2.13% | 274,629 |
24-05-31 | 367 | +5.34% | 783,272 |
24-05-30 | 348.4 | +0.20% | 329,266 |
End-of-day quote NSE India S.E., June 04, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.47% | 336M | |
+42.69% | 749B | |
+38.38% | 605B | |
-6.87% | 351B | |
+18.74% | 328B | |
+6.76% | 292B | |
+18.87% | 248B | |
-2.70% | 214B | |
+11.18% | 216B | |
+2.64% | 167B |
- Stock Market
- Equities
- SUPRIYA Stock